Three directors purchased a total of 179,737 shares and 179,737 warrants with an average purchase price of $1.224. Dr. Smith has invested in all of MAIA’s funding rounds since the Company’s inception ...

In the pilot episode of 'Pluribus', astronomers detect a mysterious radio signal originating roughly 600 light-years away ...

The transition from simple chemistry to the complex biology of molecules that gave rise to life is a puzzle that scientists ...

Researchers from Nazarbayev University's National Laboratory created the first large-scale, high-quality genotyping dataset ...

Enrollment Completed in C-BEYOND Phase 3 Trial with More Than 880 HCV Treatment-Naïve Patients in US and Canada ...

Researchers from Marshall University and the University of Missouri have developed G2PDeep, an innovative web-based platform ...

This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...

In Episode 8, while Zosia and Carol are looking through a telescope one night, Zosia explained that The Others have since learned the radio signal came from Kepler-22b.

Triage Plus was designed to detect mRNAs and DNA single-nucleotide variants from fibroblast growth factor receptor 3 and telomerase reverse transcriptase genes associated with bladder cancer.

In this interview, Dr. Gary Pestano and Dr. Prithwish Pal discuss the advantages ddPCR offers in molecular residual disease ...

Your next favorite true crime podcast might have some new forensics jargon to make sense of. Researchers in Australia have developed a new way to identify humans – similar to how we do with DNA and ...

PLX READ THE FULL PLX RESEARCH REPORT Protalix BioTherapeutics, Inc. (NYSE:PLX) announced a collaboration with the Germany-based Secarna Pharmaceuticals to develop novel antisense oligonucleotide (ASO ...